Spirapril, sold under the brand name Renormax among others, is an ACE inhibitor antihypertensive drug used to treat hypertension.

It belongs to dicarboxy group of ACE inhibitors.

[citation needed] It was patented in 1980 and approved for medical use in 1995.

[1] Like many ACE inhibitors, this prodrug is converted to the active metabolite spiraprilat following oral administration.

[3] This drug article relating to the cardiovascular system is a stub.